Aptamer Group plc (LON:APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has announced that it has conditionally raised £2.83 million (before expenses), by way of a placing and subscription of 1,415,000,000 New Ordinary Shares at an issue price of 0.2p per share for working capital purposes.
The Fundraise comprises:
· a firm placing of 116,835,918 New Ordinary Shares at the Issue Price, which is not conditional on Shareholder approval to raise approximately £0.2 million (before expenses); and
· a conditional placing of 1,272,164,082 New Ordinary Shares at the Issue Price to raise approximately £2.5 million (before expenses) and a conditional subscription for 26,000,000 New Ordinary Shares to raise £0.1 million (before expenses), each of which will require Shareholder approval at the General Meeting.
The Issue Price represents a discount of approximately 63.6 per cent. to the closing price per Ordinary Share of 0.55 pence at close of business on 23 July 2024, being the last practicable date prior to the announcement of the Fundraise.
